Javed Butler, MD, MPH, MBA, discusses heart failure in this CME activity titled, "New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap Forward in Optimizing Patient Care?" For the full presentation, downloadable infographics, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2JG2v9l. CME credit will be available until May 29, 2020.
1. A Case report of Heart Failure
2. Discussion on Heart Failure
3. Role of Peptides in Heart Failure
4. Importance of 30 days in heart failure
5. Role of ENTRESTO in Stable Heart Failure patient (PARADIGM-HF study)(HFrEF)
6. Biomarkers in Heart Failure
7. Role of ARNI in Hospitalized Heart Failure patient (PIONEER-HF study)
8. Role of ARNI in HFpEF (PARAMOUNT Trial)
9. Safety and usefulness of ACEI/ARB/ARNI
10. Role of SGPL2 inhibitors in HF with/without DM
Javed Butler, MD, MPH, MBA, discusses heart failure in this CME activity titled, "New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap Forward in Optimizing Patient Care?" For the full presentation, downloadable infographics, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2JG2v9l. CME credit will be available until May 29, 2020.
1. A Case report of Heart Failure
2. Discussion on Heart Failure
3. Role of Peptides in Heart Failure
4. Importance of 30 days in heart failure
5. Role of ENTRESTO in Stable Heart Failure patient (PARADIGM-HF study)(HFrEF)
6. Biomarkers in Heart Failure
7. Role of ARNI in Hospitalized Heart Failure patient (PIONEER-HF study)
8. Role of ARNI in HFpEF (PARAMOUNT Trial)
9. Safety and usefulness of ACEI/ARB/ARNI
10. Role of SGPL2 inhibitors in HF with/without DM
A Mistake that has Hurt No One: Sinus Mistakusasclepiuspdfs
There are times when we, the health care providers make a diagnosis and plan to treat that condition accordingly. In the mean time, because of a second opinion or another specialist consult might change the diagnosis completely and therefore the mode of management could change drastically. Here we present a similar case scenario for work-up of chest pains changing the diagnosis and therefore the mode of treatment. However in this process the patient did not get hurt (“Sinus Mistakus”).
Systemic lupus and its cardiovascular effects either on vessels or heart ( pericardium, myocardium, endocardium)
First lupus day, Beni-Suef Immunology Unit, internal medicine department
Its leftover homework of our physician scientist & health care providers for the last 75 years indeed. Contemporary challenges are numerous , but there is a will there is a way ,today or tomorrow some body some where has to start .
Currently heart failure is being treated by every physician ,any where from community to academic institution ,and is based on old system of payment ( FFP ) fee for service ,we need to switch from FFS to Value based payment ( VBP ) .
Million Heart, ticking time bomb can we predict or preventasadsoomro1960
There are different stages of HF syndromes , stage B HF is grossly neglected by cardiology community ,which is a ticking bomb to prevent symptomatic HF
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Ischemic heart failure benign or malignant
1. Acute Ischemic
Heart Failure
syndromes
Dr Asadullah Soomro
Adult cardiologist
Prince sultan cardiac centre Al-Hassa
Kingdom of Saudi Arabia.
Email;hssbasadsoomro@gmail.com
2. Ischemic heart failure syndrome type 11, with more than 100 times hospitalization. Guess what is
this??
4. Type 1V
“ Orphan Ischemic heart
failure
Syndromes”
“ Myth or reality”
5. Ischemic Type 1V Heart failure
syndromes
Conventional criteria for diagnosing Coronary
artery disease in individual patient with symptoms of
heart failure include documented acute or old
Myocardial infarction or documented typical symptoms
of stable or unstable angina , supported by reversible
myocardial ischemia, and evidence of CAD on
coronary angiogram. ( type 1 to type
111)
How ever ,in type 1V ischemic heart failure without
coronary angiogram true prevalence of ischemic heart
failure is under estimated.
6. Ischemic Type 1V Heart failure
syndromes
Elderly patients with primarily symptoms of heart failure
( type 1V) with LV Systolic dysfunction or perserved
function , 52% have CAD on coronary angiogram,
and 37%have hibernating myocardium on
myocardial perfusion imaging .
Non invasive assesment thus seriously underestimates
the prevalence of CAD and fails to identify those
patients who may benefit from revascularization.
Most cases of type 1V HF are attributable to CAD.
7. Ischemic Type 1V Heart failure
syndromes
1) Very Elderly patients with low ejection fraction are
not studied to rule out CAD as cause of heart failure .
2) Similarly elderly hypertensive patients with perserved
systolic function are usually neglected indeed
,therefore CAD as a cause of heart failure is
overlooked.
3) Heart failure with global systolic dysfunction and
LBBB despite having atheroscelrotic risk factors are
also neglected as dilated cardiomyopathy and are
presumed not suitable for coronary angiography, or
delayed , hence do not benefit from late
revascularization.
8. Ischemic Type 1V Heart failure
syndromes
4) Elderly DM,HTN & CKD ,COPD with MR & TR
associated with paroxysmal or permanent atrial
fibrillation , and low ejection fraction are denied
coronary angiography to rule out CAD as cause
of heart failure until present with acute STEMI.
5) Adults with Corrected congenital heart defects ,
with residual sequele ,baseline abnormal EKG
and ventricular dysfunction especially those
associated metabolic syndrome , are also
overlooked to rule out CAD as a etiology or
precipitant of heart failure.
9. Ischemic Type 1V Heart failure
syndromes
6) Last not the least although rare but yet we see
some patients with long standing risk factors , who
are presented with malignant cardiac
dysrrhythmias and first time symptoms of
heart failure , with severe transient LV
systolic dysfunction ,resuscitated successfully with
out EKG evidence of myocardial infarction .
They are also neglected to rule out significant CAD
with otherwise good targets of revascularization.
10. Ischemic Type 1V Heart failure
syndromes
History , EKG and Echocardiogram ,found evidence
of CAD in 42% men and 25% women predicting
HF.
However careful history in patients with high
probability of CAD may help in diagnosis of type
1V ischemic heart failure in many patients.
More recent studies using different techniques have
found higher prevalence of type 1V ischemic heart
failure syndromes .
Average 61% ( 68% in men & 38% in women) in
east Finland.
11. Back ground of
Ischemic Type 1V Heart failure syndromes
In 1995 while working at Dow Medical college & civil
hospital Karachi Pakistan, I first time discovered this small
group of ischemic heart failure patients, who were labelled
as dilated / ischemic cardiomyopathy without objective
evidence of CAD.
They had severe LV systolic dysfunction with recurrent
hospitalizations.
To establish etiology and with a view to assess if they have
suitable revascularization targets, we did coronary
angiogram in few such high risk patients.
We found in them small caliber ,multi vessel severely diffuse
,multiple lesions ,( as an ischemic etiology and precipitant
of decompensation indeed).
Considered unsuitable for revascularization , therefore
stopped further testing .
12. Background of
Ischemic Type 1V Heart failure syndromes
At that time , based on above coronary morphological
features ,I classified ischemic heart failure in four
groups .
372 HF patients audit was first time presented , in Dow
medical golden jublee symposium and later in
cardiology congress organized by pakistan cardiac
society , but was overlooked by most of the physicians.
After coming to Kingdom of Saudi Arabia ,
I continued ineterst in ischemic heart failure
syndromes, and discovered few patients with
ischemic type 1V heart failure syndromes with
more or less same coronary morphological
features. Following is one of the good example to
share in this regard.
13. Case No 1 ( 100020548)
Date &time of admission 17. 3. 2015, at 6.11 Pm
Mode of Admission: Through ER.
Date & time of Expiry: 8 . 4 . 2015 , at 10.50 Pm
(Expired on 21th day of hospitalization & 48 hours of
CABG)
DIAGNOSIS
Acute decompensated Ischemic heart failure syndrome
with Syncope .
Severe LV systolic dysfunction moderate MR, Severe TR
& pulmonary hypertension ( type 1V)
stage C . severe diffuse 3 VD
CAD .
Post CABG , haemorrhagic / cardiogenic shock
Acute hypoxic liver injury, cardio-renal syndrome.
14. Executive Summary
50 year non saudi male hypertensive & smoker
,presented to KFHH ER with history of progressive
breathlessness & fatigue for the last 6 months
became severe at rest on the day of admission.
No H/o chest pain suggestive of angina or
myocardial infarction.
Evaluated by on call ,and admitted as hypertensive
acute decompensated heart failure syndrome,
echocardiogram showed severe global LV systolic
dysfunction EF < 20%.
15. Cont,
After HF stablization ,to rule out CAD underwent
Coronary angiogram which showed severe
diffuse 3VD CAD.
Discussed in combined meeting and was
recommended for viability study, which showed
dilated LV prominent RV with increase lung
uptake.
There were two totally reversible defect in LAD &
LCX territory.
However RCA had irreversible
( non viable scar) defect EF, 19%
16. Cont,
He was re discussed and was accepted
for high risk PCI.
Later reviewed by interventionalist team
and deferred for PCI.
Again third time discussed in combined
meeting and was accepted for high risk
CABG ( Euro-score 6.4 &
mortality around 5-10%)
17. Cont,
Prepared for CABG IABP was inserted on
6th April, evaluated by pulmonologist and CT
chest was done for pleural effeusion prior to
CABG.
On 7 th April underwent CABG, all arteries
were deeply intramyocardial.
Had 4 grafts, LIMA to mid LAD, SVG to
Diagonal & PDA of the RCA. OM
was totally occluded.
18. Cont,
In recovery suddenly became hypotensive VT/Vib ,
re-opened again, bleeding points were secured,
another SV Grafting was done to LAD.
In view of his haemodynamic instability along with
IABP ,ECMO was inserted and shifted to ICU
in critical condition, on multiple ionotropes .
Bleeding continued through drains ,platelets
dropped to 42 along with HB% ,transfused
various & multiple blood products ( total 101,
Rbc, Platelets, fresh frozen plasma & Cryo
precipitates) , all invain.
19. Cont,
On 8th April again shifted to OR because of
bleeding, re-thoracotomy done, clots removed,
areas of bleeding close to LAD were again sutured.
Chest packed with three large swabs, and shifted
back to ICU.
On maximum haemodynamic support (
IABP ,ECMO & multiple ionotrops) Dialysed
through CRRT , subsequently developed hypoxic
hepatitis ( AST,ALT & LDH) in thousands.
On the same day around 10 .20 pm developed
bradycardia which progressed to asystole ,
resuscitation done but failed and expired at 10.50
Pm.
20. PAST HISTORY
6 months back was admitted to PSBJ H with H/O
progressive breathlessness FC11 & syncope .
Fell down from the bed while he was sitting alone
,recovered spontaneously after some time , sustained
fascial injury with bleeding ,therefore went to
hospital EKG & X-rays were done ,but prior to full
evaluation left against medical advise (
LAMA).
Last time admitted to KFHH with worsening of symptoms of
heart failure, however considered as suspected corona virus
and remained in isolation ward untill cleared from dammam
reports that corona is negative.
21. Echocardiogram (26.3.15)
Moderately dilated LA /LV with severe global LV
systolic dysfunction EF < 20%.
Normal RA/ RV size, and function.
Moderate Mitral Regurgitation.
Severe TR, PASP= 50 – 55 mm.
Intact septa , IVC mildly dilated.
No pericardial effusion. No Clot.
22.
23.
24. Coronary Angiogram
( 26.3.2015)
LM: 30% plaque mid and at bifurcation.
LAD: Type 3 vessel , mid 90% diffuse disease, distally
graftable .
LCX: Non dominant . CTO proximally, filling from
RCA.
RCA: Dominant, diffuse disease, 50% proximal, 75%
mid and 90% distal. PLVB diffusely diseased, PDA
occluded filling from LCA .
Conclusion :
Severe 3 VD diffuse disease for discussion.
38. Liver function test (10020548)
8.4.20157.4.2015
Post CABG
31.3.1418.3.2015Name of
Test
B+VeBlood
group
22.733.0Total
Bilirubin
5.119.0Direct
Bilirubin
NegativeHCV19156972730ALT
NegativHbs27846954736AST
NegativHIV29763185299354LDH
18.4 / 914, 133272.4/22T protein/
Albumin
190117Alpo4
39. Transfusion ( total 101 units)
( Haemorrhagic shock)
Fresh
Frozen
Plasma
22
Units
R
B
C
26
Units
Cryo
precipitate
23
Units
Plate
lets
30
Units
40. 54 year Afghani male, admitted on saturday 25th july 2015 at around 7am with extensive anterior wall
STEMI, underwent primary PCI to Single vessel totally proximally occluded LAD successfully with DES
deployment TIMI 111 flow.
Immedietely post PCI in CCU develop acute heart failure ( De-novo), simple. haemodynamically stable
without major organ dysfunction.Echo showed severe LV systolic dysfunction and no mechanical
complication.
41. 54 year Afghani male, admitted on saturday 25th july 2015 at around 7am with extensive anterior wall STEMI.EKG on right taken at 5 am in
one of the private hospital where he presented with H/O chest pain after 8 hours. EKG shows sinus tachycardia , Q waves with ST elevation in
leads 1,aCL ,V2 to V6. cardiac markers were elevated in thousands at admission. Presumbly late presentation of MI .Did PCI to totally
occluded LAD .LCX & RCA were normal. Post PCI develop acute pulmonary edema.
42. 54 year Afghani male, admitted on saturday 25th july 2015 at around 7am with
extensive anterior wall STEMI.
Coronary angiogram shows single vessel proximal acute thrombotic occlusion of
LAD after septal branch. LAD before and after PCI.
43. Acute Extensive anterior wall STEMI complicated by ( De-
novo) HF.
Type 1 , Ischemic Heart failure syndrome
44. Acute Ischemic Heart Failure syndrome ( de –nove)
Type 1V, Without clinical evidence of myocardial infarction & angina.
46. Two other ischemic heart failure
type 1V and type 1 .
( Acute anterior wall STEMI,
simple HF, SVD ,post PCI to
LAD)
Coronary anatomy and
morphology.